Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Cathy Engelbert
AddedMar 31, 2024
UpdatedMay 31, 2026
Cathy Engelbert

Cathy Engelbert

Board Member, Deloitte

LinkedIn

Cathy Engelbert's Career

Deloitte
Deloitte

London, Greater London, GB

Board Member· Board
Royalty Pharma
Royalty Pharma

New York City, NY, US

Board Member· Board
McDonald’s
McDonald’s

Chicago, IL, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Cathy Engelbert's Career

Deloitte
Deloitte
457k1845London, Greater London, GB
Board Member· Board

Recent news

Second Byju’s auditor exits in a year as financial turmoil deepensTechCrunch · 2024
QuantHealth brings its AI-informed clinical drug trials to the US with $15M roundTechCrunch · 2023
Data visualization startup Virtualitics lands $37M investmentTechCrunch · 2023

Leadership at Deloitte

Craig GiffiCraig GiffiBoard Member
Tom OmbergTom OmbergBoard Member
Greg RehGreg RehBoard Member
Rod SidesRod SidesBoard Member
William DeloitteWilliam DeloitteFounder
Jürg FrickJürg FrickBoard Member

Similar to Deloitte

KPMGKPMGAmstelveen, NLest. 1987KPMGAmstelveen, NL · est. 1987

Global Big Four professional services network providing audit, tax, and advisory services across 138 countries.

276k
CapgeminiCapgeminiParis, Paris, FRDigital Transformation, Engineeringest. 1967CapgeminiParis, Paris, FR · est. 1967

Capgemini SE is an AI-powered global consulting and technology transformation partner headquartered in Paris, France.

Public · $4M47.6k
AccentureAccentureDublin, County Dublin, IEest. 1989AccentureDublin, County Dublin, IE · est. 1989

Accenture is a global professional services company that helps enterprises reinvent through strategy, consulting, technology, operations, and AI.

Public · $6M779k
Audit SightAudit SightAtlanta, GA, USest. 2021Audit SightAtlanta, GA, US · est. 2021

Audit Sight: Streamlining client record collection through efficient API-based services.

Seed · $6.5M12
Royalty Pharma
Royalty Pharma
Public751996New York City, NY, US
Board Member· Board

Leadership at Royalty Pharma

Rory RiggsRory RiggsBoard Member
Pablo G LegorretaPablo G LegorretaBoard Member
Henry FernandezHenry FernandezBoard Member
David HodgsonDavid HodgsonBoard Member
Ted LoveTed LoveBoard Member
Christopher HiteChristopher HiteBoard Member

Similar to Royalty Pharma

Roivant SciencesRoivant SciencesNew York City, NY, USDrug Developmentest. 2014Roivant SciencesNew York City, NY, US · est. 2014

NY-based Roivant Sciences is a biopharmaceutical firm dedicated to advancing promising drugs for patient care.

Public · $2.5B267
XOMA RoyaltyXOMA RoyaltyEmeryville, CA, USRoyalty Acquisitionest. 1981XOMA RoyaltyEmeryville, CA, US · est. 1981

XOMA Corporation, a biotech royalty aggregator, acquires economic rights to clinical candidates, aiding health improvement.

Public · $295.8M96
AstraZenecaAstraZenecaCambridge, Cambridgeshire, GBPharmaceuticalsest. 1999AstraZenecaCambridge, Cambridgeshire, GB · est. 1999

AstraZeneca PLC: A British-Swedish firm specializing in research, manufacturing, and sales of pharmaceuticals.

Public · $3.8B83.5k
PharmosPharmosIselin, NJ, USDrug Developmentest. 1982PharmosIselin, NJ, US · est. 1982

W World Corp.: A bio-pharmaceutical firm innovating new drugs for neuroinflammatory disorders.

Public · $9.5M2
McDonald’s
McDonald’s
Public150k1940Chicago, IL, US
Board Member· Board

Recent news

McDonald's Reports First Quarter 2026 ResultsMcDonald's Corporation · 2026
McDonald's Reports Fourth Quarter and Full Year 2024 ResultsMcDonald's Corporation · 2025
McDonald's Announces Changes to Board of DirectorsMcDonald's Corporation · 2024

Leadership at McDonald’s

Anthony CapuanoAnthony CapuanoBoard Member
Richard LennyRichard LennyBoard Member
Enrique HernandezEnrique HernandezBoard Member
John W. RogersJohn W. RogersBoard Member
Andrew J. McKennaAndrew J. McKennaBoard Member
Miles D. WhiteMiles D. WhiteBoard Member

Cathy Engelbert's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Cathy Engelbert

Angela AhrendtsAngela AhrendtsBoard Member · WPPMelanie WhelanMelanie WhelanBoard Member · CheggLaura LangLaura LangBoard Member · Oscar HealthMindy GrossmanMindy GrossmanBoard Member · FanaticsKelli ValadeKelli ValadeBoard Member · Denny'sAnjli JainAnjli JainBoard Member · Columbia Venture Community